TickerFactsScreenerDevelopers

ADIAL PHARMACEUTICALS, INC. (ADIL) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$995.3K2018: -$6.99M2019: -$8.24M2020: -$10.93M2021: -$19.29M2022: -$10.86M2023: -$6.89M2024: -$8.28M2025: -$7.80M-$7.80M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$7.80M+5.9%
2024-$8.28M-20.3%
2023-$6.89M+36.6%
2022-$10.86M+43.7%
2021-$19.29M-76.5%
2020-$10.93M-32.5%
2019-$8.24M-18.0%
2018-$6.99M-602.0%
2017-$995.3K—